Bio-Rad Labs (BIO) Tops Q1 EPS by 10c
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $296.11 -0.39%
Revenue Growth %: -4.3%
Financial Fact:
Weighted average common shares - basic: 29.4M
Today's EPS Names:
CCEL, FEIM, PLG, More
Revenue Growth %: -4.3%
Financial Fact:
Weighted average common shares - basic: 29.4M
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q1 EPS of $1.17, $0.10 better than the analyst estimate of $1.07. Revenue for the quarter came in at $551.5 million versus the consensus estimate of $527.2 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
- FDA approves Padcev plus Keytruda for muscle-invasive bladder cancer
- Levi (LEVI) Tops Q2 EPS by 4c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
